Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Mood Disturbance: early-phase trial registry

1 of 4 indexed Mood Disturbance trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Mood Disturbance: 4 US clinical trials tracked, 1 recruiting.

Mood Disturbance is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Wayne State University, running 2 of these trials.

Enrollment posture brief

Registry condition mood-disturbance

OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 2

Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Mood Disturbance (this)25%
Open-enrollment share among volume-matched conditions near Mood Disturbance

Mood Disturbance lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mood Disturbance on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mood Disturbance is recruiting below its size-band peers.

    1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Mood Disturbance records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Written Information Behavioral
1 trials
Family Promoting Positive Emotions (F-PPE) Behavioral
1 trials
Neuroptimal (Zengar, Inc.) Neurofeedback Device
1 trials
Neurofeedback (MUSE 2) Device
1 trials
Epigallocatechin Gallate Dietary supplement
1 trials
Curcumin Dietary supplement
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Mood Disturbance trials. A trial with sites in several states counts in each.

Michigan 2 trials
Tennessee 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mood Disturbance page

4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mood Disturbance condition card totals 4 registered trials; most-linked intervention Written Information; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.